✦ LIBER ✦

A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study

✍ Scribed by Kirschbaum, Mark H.; Foon, Kenneth A.; Frankel, Paul; Ruel, Christopher; Pulone, Bernadette; Tuscano, Joseph M.; Newman, Edward M.

Book ID: 125529076
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 117 KB
Volume: 55
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.877134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study of Fludarabine, Cytarabi

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Ka 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

Phase III Trial of a Humanized Anti-CD33

Phase III Trial of a Humanized Anti-CD33 Antibody (HuM195) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

✍ Gibson, Angelia D.; Tallman, Martin S.; Jain, Vinay K. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 87 KB

International Randomized Phase III Study

International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia

✍ Roboz, G. J.; Rosenblat, T.; Arellano, M.; Gobbi, M.; Altman, J. K.; Montesinos, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 288 KB

Results of a phase 2 study of valproic a

Results of a phase 2 study of valproic acid alone or in combination with all-transretinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

✍ Andrea Kuendgen; Sabine Knipp; Frank Fox; Corinna Strupp; Barbara Hildebrandt; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 97 KB

Phase II study of nilotinib in patients

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

✍ Ottmann, O G; Larson, R A; Kantarjian, H M; le Coutre, P D; Baccarani, M; Hochha 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB